CSIMarket
 
Treace Medical Concepts Inc   (TMCI)
Other Ticker:  
 
 
Price: $12.0000 $0.12 1.010%
Day's High: $12.3 Week Perf: -2.91 %
Day's Low: $ 11.60 30 Day Perf: -23.76 %
Volume (M): 492 52 Wk High: $ 27.97
Volume (M$): $ 5,899 52 Wk Avg: $17.34
Open: $11.89 52 Wk Low: $5.27



 Market Capitalization (Millions $) 739
 Shares Outstanding (Millions) 62
 Employees -
 Revenues (TTM) (Millions $) 154
 Net Income (TTM) (Millions $) -63
 Cash Flow (TTM) (Millions $) -81
 Capital Exp. (TTM) (Millions $) 12

Treace Medical Concepts Inc
Treace Medical Concepts Inc is a medical device company that focuses on developing innovative solutions for foot and ankle conditions. The company is known for its Laser Loc' and Lapiplasty' product lines, which aim to advance the standard of care for the treatment of various foot and ankle conditions, including bunions and hammertoes. Treace Medical Concepts Inc strives to provide surgeons and patients with improved surgical approaches and outcomes through their technologically advanced and minimally invasive products.


   Company Address: 100 Palmetto Park Place Ponte Vedra 32081 FL
   Company Phone Number: 373-5940   Stock Exchange / Ticker: NASDAQ TMCI
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

Unveiling the Three-Year ALIGN3D Findings: Treace Medical Concepts Confirms Efficacy of Lapiplasty and Adductoplasty Procedures in Bunion Treatment

Published Fri, Feb 2 2024 5:00 PM UTC

In a breakthrough development, Treace Medical Concepts, Inc. (Treace), an innovator at the vanguard of surgical treatment for bunions and related midfoot deformities, has disclosed encouraging findings from its three-year interim clinical data of the ALIGN3D post-market research. This significant step forward in the realm of podiatry was formally announced during a podium pr...

Clinical Study

A Revolutionary Vision: Treace Medical Concepts' New Iterations Pave the Way for Progressive Foot and Ankle Care

Published Thu, Feb 1 2024 12:00 PM UTC

Foot and ankle care is a medical field that never stops evolving, and the driving force behind a notable fraction of this advancement is Treace Medical Concepts Inc. Recently, the company showcased its latest product innovations and disseminated the results of the ALIGN3D study at the 2024 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference.Among...

Treace Medical Concepts Inc

Treace Medical Concepts Inc. Sees Significant Revenue Surge, but Profitability Remains Elusive in Recent Fiscal Period

TMCI, a medical equipment and supplies company, recently announced a significant increase in revenue for the financial period ending September 30, 2023. The company's revenue surged by 23.304% to $40.76 million compared to the same period last year. However, TMCI also saw an increase in deficit per share at $-0.28.
In comparison to its sector contemporaries, TMCI seems to have outperformed in terms of revenue growth. The Medical Equipment & Supplies sector as a whole reported a 4.89% improvement in revenue during the same period. TMCI's sequential performance showed a growing deficit from $-0.20 per share, and a decrease in revenue by -2.848% from $41.95 million.

Treace Medical Concepts Inc

Treace Medical Concepts Inc Struggles to Reach Break-Even Point Amidst Revenue Surge in Recent Fiscal Period, Showcasing Sophisticated Performance for the Medical Equipment & Supplies Firm

The stock market is often filled with ups and downs, but amidst the volatility, there are always opportunities for investors to find success. One such opportunity lies with Treace Medical Concepts Inc (TMCI), a company that has recently announced some impressive figures.
In the most recent fiscal period, TMCI saw a remarkable 124.264% increase in revenue, reaching an impressive $41.95 million. This substantial growth shows that the company is making significant strides in its industry, and it is a positive sign for investors looking for a promising stock.

Treace Medical Concepts Inc

Treace Medical Concepts Inc Rockets to Success with $42.195 Million in Q1 2023 Revenue

Treace Medical Concepts Inc, a leading medical device company, recently announced its financial results for the first quarter of 2023. The company revealed that it earned $42.195 million in revenue during this period. This represents a substantial increase compared to the same reporting season a year ago, demonstrating solid growth and a strong momentum.
While the company's total revenue grew impressively, it also reported a net loss of $-13.454 million for the quarter. This is in contrast to a balanced book in the same reporting season a year ago. This less-than-ideal outcome is attributed to the company?s ongoing investments in research and development, as well as in sales and marketing efforts to facilitate its growth strategies. Despite the net loss, the strong revenue performance indicates that the company has a robust foundation on which it can build.






 

Treace Medical Concepts Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com